These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 13114644)

  • 21. Conditional antagonism between isoniazid and other antibacterial agents.
    SZYBALSKI W; BRYSON V
    Am Rev Tuberc; 1953 Aug; 68(2):280-3. PubMed ID: 13065698
    [No Abstract]   [Full Text] [Related]  

  • 22. A comparison between disk diffusion and microdilution for susceptibility testing of Mycobacterium fortuitum complex.
    Esteban J; Gadea I; Torres MV; Cabria F; Rollan E; Santos-O'Connor FG; Fernández-Roblas R; Soriano F
    J Chemother; 2002 Dec; 14(6):547-53. PubMed ID: 12583544
    [TBL] [Abstract][Full Text] [Related]  

  • 23. MYCOBACTERIUM FORTUITUM IN ABSCESSES OF MAN.
    BECK A
    J Clin Pathol; 1965 May; 18(3):307-13. PubMed ID: 14304242
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Mycobacterium fortuitum infection of ventriculoperitoneal shunt.
    Midani S; Rathore MH
    South Med J; 1999 Jul; 92(7):705-7. PubMed ID: 10414479
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Acetone leaf extracts of some South African trees with high activity against Escherichia coli also have good antimycobacterial activity and selectivity index.
    Elisha IL; Botha FS; Madikizela B; McGaw LJ; Eloff JN
    BMC Complement Altern Med; 2017 Jun; 17(1):327. PubMed ID: 28629354
    [TBL] [Abstract][Full Text] [Related]  

  • 26.
    Luo J; Yu X; Jiang G; Fu Y; Huo F; Ma Y; Wang F; Shang Y; Liang Q; Xue Y; Huang H
    Antimicrob Agents Chemother; 2018 Jul; 62(7):. PubMed ID: 29760127
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [ON THE PROBLEM OF ANTIMYCOBACTERIAL EFFECT AND CROSS RESISTANCE OF CAPREOMYCIN].
    TRNKA L; KUSKA J; HAVEL A
    Prax Pneumol; 1964 Dec; 18():798-802. PubMed ID: 14335595
    [No Abstract]   [Full Text] [Related]  

  • 28. [Resistance of Mycobacterium fortuitum against varied physical factors and its survival in different surroundings].
    Zhuang B; Wu C; Lin G
    Zhonghua Jie He He Hu Xi Za Zhi; 2001 Nov; 24(11):679-81. PubMed ID: 16136908
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Catalastic activity and sensitivity to Mycobacterium tuberculosis antibiotics].
    VIALLIER J; CAYRE RM
    C R Seances Soc Biol Fil; 1955 Apr; 149(7-8):734-6. PubMed ID: 13261471
    [No Abstract]   [Full Text] [Related]  

  • 30. [Determination of resistance to antibiotics in tuberculosis].
    TISON F
    Sem Hop; 1953 Jul 26-30; 29(48-49):2483-6. PubMed ID: 13089784
    [No Abstract]   [Full Text] [Related]  

  • 31. katGI and katGII encode two different catalases-peroxidases in Mycobacterium fortuitum.
    Menéndez MC; Ainsa JA; Martín C; García MJ
    J Bacteriol; 1997 Nov; 179(22):6880-6. PubMed ID: 9371430
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Resistance to antibiotics of mycobacteria of the Province of Cadiz].
    del Rey Calero J; Casal Roman M
    Rev Sanid Hig Publica (Madr); 1971 Jan; 45(1):73-114. PubMed ID: 5006012
    [No Abstract]   [Full Text] [Related]  

  • 33. Quantitative structure-activity relationship (QSAR) studies of quinolone antibacterials against M. fortuitum and M. smegmatis using theoretical molecular descriptors.
    Bagchi MC; Mills D; Basak SC
    J Mol Model; 2007 Jan; 13(1):111-20. PubMed ID: 16932890
    [TBL] [Abstract][Full Text] [Related]  

  • 34. In vitro drug susceptibility of Mycobacterium other than tubercle bacilli.
    Imwidthaya P; Komolpis P; Suthiravitayavaniz K; Rienthong S
    J Med Assoc Thai; 1990 Aug; 73(8):438-42. PubMed ID: 2262746
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Chromogenic acid-fast bacilli from human sources. IV. In vitro response to a number of antimicrobial agents on glycerol-blood agar medium.
    TARSHIS MS; WEED WA; PARKER MV; DUNHAM WB
    Am Rev Tuberc; 1955 Jul; 72(1):119-22. PubMed ID: 14388215
    [No Abstract]   [Full Text] [Related]  

  • 36. Genetic studies on microbial cross resistance to toxic agents. II. Cross resistance of Micrococcus pyogenes var. aureus to thirty-four antimicrobial drugs.
    SZYBALSKI W
    Antibiot Chemother (Northfield); 1953 Nov; 3(11):1095-103. PubMed ID: 24542854
    [No Abstract]   [Full Text] [Related]  

  • 37. Biologic changes in sulfonamide-resistant Mycobacterium ranae.
    YEGIAN D; BUDD V; MIDDLEBROOK G
    J Bacteriol; 1946 Apr; 51():479-85. PubMed ID: 20985568
    [No Abstract]   [Full Text] [Related]  

  • 38. Biochemical mechanisms of antibiotic resistance in a clinical isolate of Mycobacterium fortuitum. Presence of beta-lactamase and aminoglycoside-acetyltransferase and possible participation of altered drug transport on the resistance mechanism.
    Udou T; Mizuguchi Y; Yamada T
    Am Rev Respir Dis; 1986 Apr; 133(4):653-7. PubMed ID: 3485947
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Mutation of streptomycin-dependent Mycobacterium ranae selected from a sulfathiazole-resistant variant.
    YEGIAN D; BUDD V
    J Bacteriol; 1951 Feb; 61(2):167-70. PubMed ID: 14824094
    [No Abstract]   [Full Text] [Related]  

  • 40. Phenotypic resistance in mycobacteria: is it because I am old or fat that I resist you?
    Hammond RJ; Baron VO; Oravcova K; Lipworth S; Gillespie SH
    J Antimicrob Chemother; 2015 Oct; 70(10):2823-7. PubMed ID: 26163401
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.